Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9262 |
High Similarity |
NPD3027 |
Phase 3 |
0.9115 |
High Similarity |
NPD228 |
Approved |
0.8957 |
High Similarity |
NPD5283 |
Phase 1 |
0.877 |
High Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8609 |
High Similarity |
NPD3022 |
Approved |
0.8609 |
High Similarity |
NPD3021 |
Approved |
0.8594 |
High Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.8594 |
High Similarity |
NPD3620 |
Phase 2 |
0.845 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.845 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8362 |
Intermediate Similarity |
NPD2684 |
Approved |
0.8361 |
Intermediate Similarity |
NPD1357 |
Approved |
0.8235 |
Intermediate Similarity |
NPD7843 |
Approved |
0.8197 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.8182 |
Intermediate Similarity |
NPD7157 |
Approved |
0.814 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8088 |
Intermediate Similarity |
NPD3060 |
Approved |
0.8062 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8031 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.803 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7955 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7895 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7891 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7891 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7876 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7876 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7857 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7846 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7826 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7826 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7815 |
Intermediate Similarity |
NPD290 |
Approved |
0.7812 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7788 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7788 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7788 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7786 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7786 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7786 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7744 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7744 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7744 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7744 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7744 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7742 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7734 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7731 |
Intermediate Similarity |
NPD968 |
Approved |
0.7727 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7698 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7698 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7698 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7692 |
Intermediate Similarity |
NPD291 |
Approved |
0.7686 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7681 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7669 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7643 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7643 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7619 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7615 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7615 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7612 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7594 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7591 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7591 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7591 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7574 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7574 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7574 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7557 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7556 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7538 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7538 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7519 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD5535 |
Approved |
0.75 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7482 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7481 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7481 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7464 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7464 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7462 |
Intermediate Similarity |
NPD3092 |
Approved |
0.7462 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7447 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7447 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7442 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7442 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7429 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7426 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7426 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7424 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7422 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7422 |
Intermediate Similarity |
NPD3091 |
Approved |
0.741 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.741 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7405 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7405 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7405 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7394 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7394 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7377 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7372 |
Intermediate Similarity |
NPD3059 |
Approved |
0.7372 |
Intermediate Similarity |
NPD3062 |
Approved |
0.7372 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7372 |
Intermediate Similarity |
NPD3061 |
Approved |
0.7372 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7364 |
Intermediate Similarity |
NPD1651 |
Approved |
0.736 |
Intermediate Similarity |
NPD821 |
Approved |
0.7348 |
Intermediate Similarity |
NPD1669 |
Approved |
0.7348 |
Intermediate Similarity |
NPD3685 |
Discontinued |
0.7348 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7328 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7328 |
Intermediate Similarity |
NPD1432 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD37 |
Approved |
0.7313 |
Intermediate Similarity |
NPD4624 |
Approved |
0.731 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7308 |
Intermediate Similarity |
NPD9384 |
Approved |
0.7308 |
Intermediate Similarity |
NPD9381 |
Approved |
0.7305 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7305 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7303 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7293 |
Intermediate Similarity |
NPD1283 |
Approved |
0.729 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7279 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4535 |
Phase 3 |
0.7267 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7266 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7266 |
Intermediate Similarity |
NPD3596 |
Phase 2 |
0.7266 |
Intermediate Similarity |
NPD5314 |
Approved |
0.7265 |
Intermediate Similarity |
NPD844 |
Approved |
0.726 |
Intermediate Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD52 |
Approved |
0.726 |
Intermediate Similarity |
NPD7526 |
Approved |
0.7254 |
Intermediate Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.7252 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7239 |
Intermediate Similarity |
NPD3053 |
Approved |
0.7239 |
Intermediate Similarity |
NPD3055 |
Approved |
0.7234 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7234 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7231 |
Intermediate Similarity |
NPD5691 |
Approved |
0.723 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7222 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7222 |
Intermediate Similarity |
NPD9379 |
Approved |
0.7222 |
Intermediate Similarity |
NPD9377 |
Approved |
0.7218 |
Intermediate Similarity |
NPD9622 |
Approved |
0.72 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD709 |
Approved |
0.7185 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7183 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7183 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD3095 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7171 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7171 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7167 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7164 |
Intermediate Similarity |
NPD5311 |
Approved |
0.7164 |
Intermediate Similarity |
NPD5310 |
Approved |
0.7163 |
Intermediate Similarity |
NPD2156 |
Approved |
0.7163 |
Intermediate Similarity |
NPD2155 |
Approved |
0.7163 |
Intermediate Similarity |
NPD2154 |
Approved |
0.7162 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7162 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7154 |
Intermediate Similarity |
NPD6581 |
Approved |
0.7154 |
Intermediate Similarity |
NPD6580 |
Approved |
0.7154 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7154 |
Intermediate Similarity |
NPD1182 |
Approved |
0.7154 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7153 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD3054 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3052 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7133 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD2808 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD7153 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7123 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7122
|
Intermediate Similarity |
NPD3597 |
Clinical (unspecified phase) |